Pharmaceuticals, Biotechnology and Life Sciences
Topline results for Phase 3 Pivotal Cardigan I and Cardigan II studies expected in Q4 2021BOULDER, Colo., June 29, 2021…
— Recorded Fourth Quarter Revenue of $27.6 Million and Annual Revenue of $95.9 Million — — Achieved Four Consecutive Quarters…
NEW HAVEN, Conn., June 29, 2021 (GLOBE NEWSWIRE) — Bioasis Technologies Inc. (“Bioasis” or the “Company”) (TSX.V:BTI; OTCQB:BIOAF), a pre-clinical,…
UNIONDALE, N.Y., June 29, 2021 (GLOBE NEWSWIRE) — Angion Biomedica Corp. (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery,…
Open Investigational New Drug Application (IND) with U.S. Food and Drug Administration (FDA) for Phase III study of nomacopan in…
AdCOVID was well tolerated but did not stimulate an adequate immune response in healthy volunteersAltimmune will discontinue further development of…
NEW YORK and SAN DIEGO, June 28, 2021 (GLOBE NEWSWIRE) — Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company…
REDWOOD CITY, Calif., June 28, 2021 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a preclinical-stage biopharmaceutical company focused…
MONTRÉAL, June 28, 2021 (GLOBE NEWSWIRE) — IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported that…
WATERTOWN, Mass., June 28, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein…